Sotera Health Company
Price Action
Technical Summary
EMERGING TRENDSotera Health Company is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 37), showing significant lag compared to the market leaders. Earnings growth of 292% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $15.68 | +0.77% | ABOVE |
| 50 SMA | $14.95 | +5.71% | ABOVE |
| 100 SMA | $16.42 | -3.80% | BELOW |
| 150 SMA | $16.40 | -3.63% | BELOW |
| 200 SMA | $15.99 | -1.16% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SHC in an uptrend right now?
SHC has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is SHC overbought or oversold?
SHC's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is SHC outperforming the market?
SHC has a Relative Strength (RS) Rating of 37 out of 99. SHC is currently lagging the broader market.
Where is SHC in its 52-week range?
SHC is trading at $15.80, which is 80% of its 52-week high ($19.85) and 55% above its 52-week low ($10.80).
How volatile is SHC?
SHC has a Beta of 1.32 and 52-week volatility of 39%. It's more volatile than the S&P 500 - expect bigger swings.